- Review
- Korean J Med. 2004;67(1):325-326.
- (Methylenetetrahydrofolate reductase, thymidilate synthase and dihydropyrimidine dehydrogenase gene polymorphismsin Korean gastric cancer patients: Genomic predictor of clinical response to capecitabine-based chemotherapy)
- ,
- Joon H. Kim, Yeon H. Park
 |
 |
 |
 |
 |
 |